1271683

Kappa Laboratories, Inc. — FEI 1039390

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 4, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
361321 CFR 211.160(b)(4)Establishment of calibration procedures
457621 CFR 211.192No written record of investigation